MedPath

Prevalence of Cachexia in Patients Undergoing Chemotherapy

Completed
Conditions
Cachexia
Cancer
Registration Number
NCT01939340
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

Cachexia and low nutritional intake are a common phenomena in cancer patients undergoing chemotherapy. The purpose of this study is to assess prevalence of cachexia and low nutritional intake and the impact on quality of life, fatigue and mortality in patients undergoing chemotherapy. Furthermore interactions between these parameters, tumor disease and chemotherapy, respectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
285
Inclusion Criteria
  • Patients undergoing chemotherapy at least in the second cycle.
  • Patients who have signed a written Informed Consent.
Exclusion Criteria
  • Patients with implanted pacemaker or defibrillator.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Nutritional intake1 day

Nutritional intake will be assessed by 24h-recall, which will be analysed with regard to macronutritients

Secondary Outcome Measures
NameTimeMethod
Mortality6 months

Mortality will be assesses via telephone or consultation of the local death register

Quality of life and fatigue1 day

EORTC QLQ C-30 will be used to assess quality of life and additionally cancer-related fatigue will be evaluated using Brief Fatigue Inventory.

Cachexia1 day

Cachexia will be evaluated using the patient-generated Subjective Global Assessment.

Trial Locations

Locations (1)

Dept. of Gastroenterology, Infectiology and Rheumatology (including workspace nutrition medicine), Charité Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath